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Hydroxyapatite (HA) has been widely used as a scaffold material for bone tissue engineering. It 
has an excellent biocompatibility but a low biodegradability. The calcium content in HA is 
thought to have an important effect on the degradation of the scaffold. The purpose of this thesis 
was to fabricate a highly porous HA foam using an emulsion direct foaming method by 
infiltration of calcium salt solution with different calcium concentration (2mol/L and 5mol/L) 
and sintering process. After that foam were immersed in Tris-bufffer Saline (TBS) at several 
different time points. We investigated the inﬂuence of infiltrated calcium salt in terms of their 
effects on weight loss/gain, surface morphology, and microstructural-level degradation with 
SEM observation and micro-CT. Interestingly there were a large amount of precipitation of 
calcium phases and detectable weight gain for the 2M samples. And for 5M samples, weight loss 
with time and a better dissolution behavior were observed. 
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1.0  INTRODUCTION 
Tissue engineering is one of the main approaches to tissue replacement such as bone repair1 and 
heart transplantation 2 . The bone marrow transplantation includes bone marrow cell 
transplantation and hematopoietic stem cells transplantation (HSCT). HSCT was first developed 
in the 1950s and has become the most effective therapy for leukemia3. Besides that HSCT is also 
used in treatments for blood cancers and multiple myeloma. According to the survey conducted 
by the Worldwide Network for Blood and Marrow Transplantation, 51,536 hematopoietic stem 
cell transplantations were reported to have occurred in 72 countries in 20084. However there are 
several problems in clinical application for HSCT. Allogeneic (the stem cells come from the 
donor) HSCT has the incidence of graft-versus-host disease because the cells in the host body 
may be attacked by the white blood cells from the donor5. Although autologous (the stem cells 
come from the patient) HSCT can avoid this problem, this option is inhibited by the low 
availability of the patients own HSCs for re-implantation that mean it is difficult to obtain an 
enough number of HSCs from the patient after a partial or complete bone marrow ablation6.  
Scaffolds are widely used biomaterials in bone tissue engineering, they can be 
synthesized in the laboratory using varieties of chemical approaches. Biocompatibility and 
biodegradability are the two most important requirements. Biocompatibility promotes cell 
adhesion and proliferation while biodegradability allows the replacement of scaffold with natural 
tissues and degradation into nontoxic products that can be resorbed by human body. In order to 
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simulate trabecular bone in clinic application, biomaterials scaffolds should be able to offer a 
similar structure and chemical microenvironment to trabecular bone. Macroporous calcium 
phosphate foams with high porosity and large open pore architectures should be the appropriate 
biomaterial for bone marrow cell culturing and bone reconstruction. Hydroxyapatite has a similar 
chemical composition to the inorganic phase of human bone. It has been widely used as artificial 
bone and bone substrate because it has a great bioactivity and biocompatibility. But the low 
biodegradability of HA impedes bone ingrowth and limits the application of HA as a scaffold 
biomaterial.  
This thesis is based on the hypothesis that by introducing Ca rich phases, Ca infiltration 
of porous HA foams has the ability of increasing the solubility of the foams during bone marrow 
culturing. In particular, the ability of the calcium rich phases to induce the fragmentation of HA 
foams was studied. 
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2.0  BACKGROUND 
2.1 REGENERATIVE MEDICINE 
Regenerative medicine is defined as the fast developing interdisciplinary field of clinical 
therapies for the reconstruction, repair, replacement or regeneration of missing or damaged cells, 
tissues or organs, to restore its native architecture or function7. It includes cell therapy, gene 
therapy, tissue engineering and other methods that have enormous potential to treat and cure 
diseases8. 
2.1.1 Cell Therapy 
Cell therapy can be defined as therapy in which cellular material is injected into a patient9. There 
are two branches of cell therapy, one is transplanting human cells from a donor to a patient 
which is established and legitimate, and the other is injecting animal cells into humans to treat 
disease which is much more dangerous. The origins of cell therapy can perhaps be traced to the 
nineteenth century, when Charles-Édouard Brown-Séquard (1817–1894) injected animal testicle 
extracts in an attempt to stop the effects of aging10. Although such attempts produced no positive 
benefit, further research in the mid twentieth century found that human cells could be used to 
help prevent the human body rejecting transplanted organs, leading in time to successful bone 
marrow transplantation11. 
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2.1.2 Tissue Engineering 
Tissue engineering is the use of a combination of cells, engineering and materials methods, and 
physicochemical factors to improve or replace biological functions. Although most definitions of 
tissue engineering cover a broad range of applications, in practice the term is closely associated 
with procedures that repair or replace portions of or whole tissues (i.e., muscle, skin, blood 
vessels, bladder, bone, cartilage etc.). 
2.1.3 Biomaterials 
A biomaterial is any surface, matter, or construct which interacts with living systems. Scaffolds 
are widely used biomaterials in bone tissue engineering, they can be synthesized in the 
laboratory using varieties of chemical approaches. Scaffolds must fulfill a range of requirements 
such as appropriate mechanical strength and stiffness, bioactive behavior, interconnected pore 
structure and bio-resorb-ability at predetermined rates12. Biocompatibility and biodegradability 
are the two most important requirements of scaffold materials, biocompatibility promotes cell 
adhesion and proliferation, while biodegradability allows the replacement of scaffold with 
natural tissues and degradation into nontoxic products that can be excreted or resorbed by human 
body. Porosity is another requirement of scaffolds, to accommodate cell reproduction and 
differentiation in tissues formation. Porosity plays an important role in regulating the bioactivity 
of a scaffold because of its influence on structural permeability that controls the initial rate of 
bone regeneration and also impacts the local mechanical environment experienced by the cells 
which mediates the equilibrium volume of new bone within the repair site13. Moreover, the 
scaffold should be capable of being formed into the desired shapes for use in a particular repair 
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site and sterilized for clinical use. Generally the biomaterials used to construct these porous 
scaffolds include: (i) synthetic biodegradable polymers such as poly (glycolic acid) (PGA), poly 
(lactic acid) (PLA), and their copolymer poly (DL-lactic-co-glycolic acid) (PLGA), and naturally 
derived polymers such as collagen and (ii) synthetic ceramics such as calcium phosphates14. 
Among the calcium phosphate, Hydroxyapatite (HA) and β-tricalcium phosphate (-TCP) are the 
major phases used for culturing human mesenchymal stem cells (MSC) necessary for bone 
formation. Their similarity in composition and structure to the mineral phase of bone provides 
both high bioactivity and biocompatibility. Comparing with tricalcium phosphate, 
Hydroxyapatite is more effective at osteoconduction but has lower biodegradability. In 
consequence, biphasic mixtures of Ha and TCP are commonly used to achieve the best 
combination of osteoconduction and biodegradation. 
2.1.4 Bioreactor 
In the context of cell expansion or tissue formation, bioreactors may be defined as a device or 
system meant for growing cells or tissues. In tissue engineering and biochemical engineering, 
there are mainly two types of bioreactor stirred tank and the perfusion. A typical stirred-tank 
bioreactor is shown in Figure 2.1. Stirred tank bioreactor can be used to expand cell numbers and 
produce cell aggregates in dilute conditions. If a scaffold is used the cells are seeded by 
convection in the liquid medium. In the tank, the growth medium is continuously refreshed and 
filters are used to ensure the cells remain in the bioreactor core. The great advantage of stirred 
tank bioreactor over static culture is efficient perfusion of the cells and effective mixing of the 
media. This avoids the sharp changes in media concentration when media is periodically 
replaced during static culture. However the central portions of unvascularized scaffolds will be 
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subject to a different local media environment compared to the external surfaces of the scaffold 
when one relies on convection to transport media into the interior of scaffolds in a stirred tank 
bioreactor15. Consequently larger scaffolds can remain acellular in their interior. Furthermore, 
mechanical shear generated in the fluid of a stirred tank bioreactor can effect cell surface marker 
expression and result in undesirable effects on the culture16. In bone marrow researches, stirred 
tank bioreactors have been proved more successful in hematopoietic stem cell and progenitor 
expansion than static culturing17. To some degree, stirred tank reactors can allow the formation 
of multi-cell aggregates, especially with microcarriers which accommodate the requirements of 
adherent cell populations. For example, embryonic stem cells have shown greater expansion in 
stirred tank bioreactors compared to static culturing both as aggregates and in microcarriers18. 
 
 Figure 2.1. Stirred tank bioreactor 
The other type of bioreactor is the perfusion bioreactor that include packed bed reactors 
and hollow fiber membrane reactors such as the one shown in Figure 2.2. Perfusion bioreactors 
are a better representation of physiological conditions in the body because cells are immobilized 
in a reactor core and media is perfused around them. In comparison with stirred tank bioreactors 
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uniform perfusion of the cells can be more difficult to accomplish in perfusion bioreactors and is 
quite sensitive to the architecture of the core. In principle, perfusion bioreactors offer the 
potential for controlled tissue formation from multiple cell types if the perfusion is controlled at 
sufficiently small length scales. Generally perfusion bioreactors can be classified as two 
dimensional bioreactors and three dimensional bioreactors. Three dimensional bioreactors are 
further differentiated into two types including direct perfusion systems and hollow fiber 
membrane reactors. In respect to stem cells research, three dimensional perfusion systems have 
achieved notable success in culturing of mesenchymal stem cells. For example, the mesenchymal 
stem cells have been shown to retain their multi-lineage potential in three dimensional perfusion 
bioreactors than static system19. 
 
Figure 2.2 Perfusion geometry for hollow fiber membrane reactor 
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2.2 BONE MARROW 
The mineral phase of bone consists of hydroxyapatite Ca10 (PO4)6(OH) 2 crystals deposited within 
a relatively small amount of organic matrix (~95% is type I collagen)20. There are two main 
types of bone architecture: cortical bone and trabecular bone (Figure 2.3). Cortical bone, also 
called compact bone, is commonly the hard outer layer on large bone that is responsible for 
structural integrity. The osteon is the main anatomical and functional unit of cortical bone. Each 
osteon is composed of concentric layers, or lamellae, of cortical bone that surround a central 
canal called the Haversian canal21. Cortical bone provides several of the structural functions of 
bone, such as supporting the whole body, protecting organs, providing levers for movement, and 
storing and releasing important physiological elements, particularly calcium. The other type is 
trabecular bone which is also called cancellous bone or spongy bone. Trabecular bone is highly 
porous and fills the interior of the large bones. Trabecular bone is highly vascularized and often 
includes red bone marrow where hematopoiesis, the production of blood cells, occurs. 
Trabecular bone is far less dense than cortical bone and contributes about 20% of the weight of a 
human skeleton. 
 
Figure 2.3 Cortical bone & trabecular bone 
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Bone marrow is the flexible tissue in the interior of trabecular bones and constitutes 4% 
of the total body mass of humans on average. There are two types of bone marrow, one is red 
marrow which is mainly made up of hematopoietic tissue and the other is yellow marrow which 
consists of fat cells (Figure 2.4).  Red marrow contains red blood cells, platelets, and white blood 
cells and both types of bone marrow contain a plentiful number of blood vessels and capillaries. 
All the bone marrow of a new born baby is red marrow, but then some is converted to yellow 
marrow during growing and only about half of the bone marrow is red when he/she becomes an 
adult. 
 
Figure 2.4 Red marrow and yellow marrow 
2.2.1 Hematopoietic stem cell 
Hematopoietic stem cells (HSCs) are the stem cells that generate all the other blood cells and 
immune system cells in the body through the process of hematopoiesis. They are derived from 
the mesoderm and located in the red bone marrow. Differentiation into progenitors and mature 
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cells and self-renew define the core function of HSCs. HSCs are able to replenish all mature 
blood cell types and also replenish their number with the same or very similar potential22(Figure 
2.5). Importantly, a small number of HSCs can expand to create an enormous number of 
daughter HSCs and progenitors 23 . This phenomenon is widely used in bone marrow 
transplantation in which a small number of HSC can be used to reform entire the hematopoietic 
system. This process shows that symmetrical cell divisions into two daughter HSCs must happen 
to a large extent. In order to keep steady state levels in the peripheral circulation, the HSCs 
produce 1011–1012 blood cells every day and use the bone marrow vasculature as a conduit to the 
body's circulation system24. Stem cell self-renewal also occurs in the stem cell niche within the 
bone marrow. Related studies have showed that there appear to be two kinds of HSCs. If bone 
marrow cells from the transplanted from one person to another person and restore their 
hematopoietic system of an extended period, they are recognized as long-term HSCs that are 
capable of self-renewal25. Other HSCs which can regenerate all the types of blood cells but 
cannot self-renew over the long term under normal circumstances, are considered as short-term 
HSCs, progenitor or precursor cells. 
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Figure 2.5 Hematopoietic differentiation 
2.2.2 Hematopoietic stem cell transplantation 
Bone marrow is the best known location for HSCs, and bone marrow transplantation has become 
synonymous with hematopoietic cell transplantation. Hematopoietic stem cell 
transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, derived 
from not only bone marrow but also peripheral blood in the circulation system and umbilical 
cord blood sources. This transplantation is often performed for patients with some cancers of 
the blood or bone marrow, such as multiple myeloma or leukemia26. 
HSCT can be divided into two kinds, autologous (the stem cells come from the patient) 
and allogeneic (the stem cells come from the donor). Autologous HSCT requires that the stem 
cells should be stored in a freezer after being extracted from the patient. Then the patient is 
treated with high dose chemotherapy with radiotherapy resulting in partial or complete bone 
 12 
marrow ablation, which means patient's bone marrow's ability to grow new blood cells will 
disappear. After that the stored stem cells are thawed and transfused into the patient, the 
destroyed tissue will be replaced with new bone marrow and the normal blood cell production 
will be resumed. Autologous transplants have lower risk of infection during the immune-
compromised section of the treatment because the immune function is able to recover quickly. 
Additionally, the incidence of graft-versus-host disease (GVHD) is very rare since the recipient 
and donor is the same individual. These advantages have established autologous HSCT as one of 
the standard second-line treatments for such diseases as lymphoma27. However, for other cancers 
such as acute myeloid leukemia, the autogenous HSCT may have a higher possibility of cancer 
relapse and related mortality compared with allogeneic HSCT, therefore the allogeneic treatment 
may be better for those conditions28. 
In allogeneic HSCT, stem cells are extracted from the (healthy) donor and then 
transplanted into the (patient) recipient. Allogeneic HSC donors must have a tissue type that 
matches the recipient based on the variability at three or more loci of the human leukocyte 
antigen (HLA) gene29. The recipient will still need immunosuppressive medications to minimize 
graft-versus-host disease (GVHD) even though there is a good match at the critical alleles30. 
Allogeneic transplant donors may be related, syngeneic or unrelated to recipients. In generally, 
by transplanting healthy stem cells to the recipient's bloodstream to reform a healthy immune 
system, allogeneic HSCTs can improve chances for cure or long-term remission once the 
immediate transplant-related complications are resolved31 32 33 . Doing additional HLA-testing 
from the blood of potential donors is the way to find a suitable donor. The HLA genes split into 
two categories (Type I and Type II). Generally, mismatches of the Type-I genes increase the risk 
of graft rejection while mismatches of the Type II gene increases the risk of graft-versus-host 
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disease (GVHD). In addition, even a mismatch as small as a single DNA base pair is significant, 
therefore the knowledge of the exact DNA sequence of the genes for both donor and recipient is 
required. Indeed, if bioreactors could be used to expand the supply of available bone marrow 
stem cells and progenitors to clinically relevant amounts, greater flexibility would be achieved 
for transplantation services. 
2.3 CALCIUM PHOSPHATE 
2.3.1 Hydroxyapatite 
Hydroxyapatite (HA) is a naturally occurring mineral form of calcium apatite, its formula is Ca5 
(PO4)3(OH) but it is generally written as Ca10 (PO4)6(OH)2 to show that the crystal unit cell 
comprises two formula units. Hydroxyapatite has a hexagonal crystal structure with space group 
P63/m and 44 atoms per unit cell. Stoichiometric HA has a Ca/P ratio of 1.67, and unit cell 
dimensions of a=b=9.432Å and c=6.881Å. The structure of an HA unit cell is shown in Fig. 3.1. 
 
Figure 2.6 Crystal structure of HA34 
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Hydroxyapatite is the hydroxyl endmember of the complex apatite group. The OH− ion 
can be replaced by chloride, fluoride, or carbonate, forming chlorapatite or fluorapatite35. Pure 
hydroxyapatite powder is white. Naturally existing apatites can also have grey, yellow, brown, or 
green colorations, comparable to the discolorations of dental fluorosis. 
Hydroxyapatite (HA) has a similar chemical composition to the inorganic phase of 
human bone and teeth 36 . HA is widely used in biomedical area for its bioactivity and 
biocompatibility. But HA has some poor mechanical properties such as the brittleness and low 
fracture toughness, which can limit its applications to non-load bearing or metallic implant 
surfaces coating 37 . The tensile strength of the synthetic dense HA and cortical bone are 
respectively 68.49-191.78 Mpa and 68.49 Mpa, and the compressive strength of the synthetic 
dense HA and cortical bone are 205.48-890.41 Mpa and 136.99 Mpa38. In addition the Young’s 
Modulus of cortical bone is 1.38x104 Mpa, while that of HA is 3.42-10.27x104 Mpa. HA is also 
harder than bone and bulk HA implants have low reliability under tensile loading possibly can 
result in catastrophic failure in clinic use. Some improvement in the mechanical properties of HA 
ceramics, has been achieved by making composites and controlled microstructures via different 
sintering techniques and nanostructured powders 39 . However, the improvements have been 
limited. 
As a bioactive material, the most important advantage of HA is that a direct chemical 
bond can be achieved between bone and HA implants without the formation of a collagen 
interface layer which usually occurs on many other bio-inert materials after implantation40. The 
bond strength between HA and bone is much higher than between bone and other materials 
because of the direct chemical bonding. In addition there is no fibrous tissue capsule between the 
implant and bone which is significant for the patient’s recovery after implantation41. 
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HA degradation rate is not strongly related to processing variables including: purity, HA 
form (bulk form, porous form, coating, and HA/polymer composites), microstructure, implant 
site and body conditions42. Indeed, the rate of resorption of HA is generally considered to be too 
low to allow timely restructuring of the tissue in the scaffold and so materials with faster 
degradation rates, such as TCP, have been incorporated into biphasic calcium phosphate 
scaffolds. 
2.3.2 Tricalcium phosphate 
Tricalcium phosphate (TCP) is a calcium salt of phosphoric acid, its chemical formula is 
Ca3(PO4)2. It is also called tribasic calcium phosphate and bone phosphate of lime (BPL). 
Tricalcium phosphate has three crystalline polymorphs, β-TCP, α- TCP and α′-TCP, depending 
on temperature43. The α′-TCP is stable only in equilibrium at temperatures higher than 1430 OC 
and converts back to α-TCP below the transition temperature. The β-TCP and the α- TCP forms 
can both be achieved at room temperature even though the transition from β-TCP to α- TCP 
occurs at 1125 OC44. The β-TCP has a crystallographic density of 3.066 g cm−3, the α-TCP has a 
density of 2.866 g cm−3 and α'-TCP has a density of 2.702 g cm−3. 
β-TCP has a rhombohedral structure with unit-cell parameters a=b=10.4352Å, 
c=37.4029Å, α=β=90°, and γ=120° in the hexagonal setting (space group R3c)45. There are 273 
atoms or 21 formula units per unit cell. α-TCP has a monoclinic structure (space group P21/a) 
with unit-cell parameters a=12.8328 Å, b=27.1958 Å, c=15.1656 Å, α=γ=90° and β=126.2°. 
Each unit cell contains 312 atoms or 24 formula units. All kinds of TCP are described as 
containing "columns" of cations and anions. The α-TCP consists of two types of ion columns 
aligned along the (0 1 0) direction, as shown in Figure 2.7a. Column A consists of Ca2+ ions and 
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column B consists of Ca2+ and PO4
-3 ions. The crystal structure of β-TCP can be described by A 
and B columns, running along the c-axis46 (Figure 2.7). Each A column is surrounded by six B 
columns, while each B column is surrounded by two A and four B columns. 
 
Figure 2.7 Crystal structure of α-and β-TCP45 
Some related studies have shown that β-TCP is mechanically stronger than α-TCP, for 
the reason that some bonds of PO4 groups formed in β-TCP are stronger than the bonds of α-
TCP. In clinic application(dentistry, orthopedic surgery, bone repair, etc.), β-TCP is more widely 
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used as biomaterials such as macro-porous bioceramics, while α-TCP is usually used as a fine 
powder for calcium phosphate cements due to its higher solubility and biodegradability4748. 
2.3.3 Solubility of HA and TCP 
Calcium phosphates can be remodeled by the osteoblasts and osteocytes in biological processes. 
These materials can also dissolve in aqueous solution. In the dissolution process, Ca2+ ions and 
PO4
3- ions are released from the ceramic scaffold into the solutions and eventually influence the 
cell culture environment. Calcium is known to influence cells residing in the bone marrow niche 
cells, such as osteoblasts and endothelial cells49. Therefore a calcium phosphate scaffold can 
affect the HSC niche and HSC fate by releasing calcium. This is the reason that solubility of 
calcium phosphates can be important to culturing HSCs on scaffolds in clinic application. 
Many factors affect the dissolution behavior of HA, β-TCP, α-TCP, such as the technique 
of preparation, phase content, density and the extent of ionic substitutions into the apatite lattice 
and microstructure50,51. Fig. 3.3 shows solubility of calcium phosphates with different Ca/P ratio 
as a function of pH. From the figure, it is obvious that the order of solubility is α-TCP>β-TCP> 
HA. At pH=7.3, which is general bone marrow culture pH condition, calcium carbonate has a 
solubility at around 10-2.5 which is highest solubility in the calcium phosphates. Then it was 
followed by Tetracalcium phosphate (TeCP) and α-TCP. The solubilities of these two phases are 
about the same that is 10-2.6. The solubilities of β-TCP and HA respectively are10-3.5 and 10-4.3. 
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Figure 2.8 Solubility isothermal of calcium phosphates with different Ca/P ratio in water52 
2.4 PROCESSING OF MACROPOROUS CERAMIC FOAMS 
Trabecular bone consist of macroporous (55-70% interconnected porosity) calcium 
hydroxyapatite (HA)53. The macroporosity in the trabecular bones promotes the ingrowth of the 
soft tissues and vascularization of the bone marrow. In order to simulate trabecular bone in clinic 
application, biomaterials scaffolds should be able to offer a temporary support for the cells 
facilitate cell attachment. Additionally, the scaffold also needs to provide a similar chemical 
microenvironment to trabecular bone. Macroporous calcium phosphate foams with high pore 
fractions (greater than 80%) and large open pore architectures should be the appropriate 
biomaterial for bone marrow cell culturing as well as bone repair and reconstruction. 
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Porous materials are classiﬁed into three types depending on the pore diameter d: macro-
porous (d>50 nm), meso-porous (50 nm>d>2 nm) and microporous (d>2 nm), on the basis of the 
nomenclature of IUPAC (International Union of Pure and Applied Chemistry)54. Most attention 
is placed on the fabrication of open macroporous bioceramics because the pore network allows 
the tissue to infiltrate, which further promotes the attachment between the implants and tissues in 
bone repair55. In a porous form, hydroxyapatite ceramics can be colonized by bone tissue with 
the same characteristics as peri-implanted tissues56. According to some researchers, the pore size 
must be larger than 50-100μm or even 250-300μm to insure vascularization57. 
 
Figure 2.9 Typical porosity and average pore size achieved via the replica, sacriﬁcial templating, 
and direct foaming processing methods58 
The most straightforward and conventional processing approach for the preparation of 
porous bioceramics is the partial sintering59. But this method often results in a relatively low 
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porosity (<60 vol%), with pores homogeneously distributed within the microstructure. This low 
porosity is not suitable for bone tissue ingrowth. Thus many novel methods for the preparation of 
macroporous ceramics with controlled microstructure have been developed recently. Figure 2.9 
shows typical porosity and average pore size achieved via different processing routes. The 
processing methods described in this chapter are classiﬁed into replication, sacriﬁcial templating 
and direct foaming methods, as schematically illustrated in Figure 2.10. 
 
Figure 2.10 Scheme of three main processing routes for macroporous ceramics60 
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2.4.1 Replication 
The replication method is based on the impregnation of a preexisting cellular architecture, 
usually a polymer foam, with a ceramic suspension or precursor solution in order to fabricate a 
macroporous ceramic with the same morphology as the original porous material (Fig. 4.2(a)). 
Synthetic and natural cellular structures are two types of templates to fabricate macroporous 
ceramics. In the polymer replica approach, a highly porous polymeric sponge is soaked into a 
ceramic suspension till the ceramic material fills in the internal pores. Then roller compression is 
applied to the impregnated sponge to remove the redundant suspension and enable a thin ceramic 
coating to form over the struts of the original cellular structure. After that the polymeric template 
is dried and pyrolyzed through careful heating between 300℃ and 800℃. Finally the ceramic 
coating is sintered in an suitable atmosphere at temperatures ranging from 1100℃ to 1700℃ 
(depending on material) after the polymeric template was removed. 
Porous ceramics obtained with the sponge replication method can achieve total open 
porosity levels within the range 40%–95% and the interconnected pores can reach the sizes from 
200μm to 3 mm61. In replication methods, a variety of ceramic cell types can be fabricated, 
including open-cells, semi-closed cells and closed-cells49. There is a disadvantage of the sponge 
replication method in that the struts of the reticulated structure are often cracked during pyrolysis 
of the polymeric template, signally degrading the ﬁnal mechanical strength of the porous 
ceramic62. Some possible ways to avoid this have been discovered, such as using additives to 
improve the wetting of the suspension on the sponge63, performing a second impregnation step to 
ﬁll the cracks in the ceramic struts, and introducing ﬁbers to improve the integrity of the 
material. 
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2.4.2 Sacrificial template method 
The sacriﬁcial template technique usually includes the preparation of a biphasic composite 
comprising a continuous matrix of ceramic particles (or precursors) and a dispersed sacriﬁcial 
phase. The sacrificial phase is originally homogeneously distributed in the matrix and finally 
extracted to produce pores within the microstructure (Fig. 4.2(b)). In this approach, the sacrificial 
phase is intended to produce porous materials as a negative replica. The biphasic composite is 
usually prepared in three ways: (1) pressing the powder mixed as two components 64 , (2) 
generating a two-phase suspension that is subsequently processed by wet colloidal routes such as 
slip, tape or direct casting65, (3) impregnating previously consolidated preforms of the sacriﬁcial 
material with a preceramic polymer or ceramic suspension66. The type of pore former employed 
decides the way of extracting the sacriﬁcial material from the consolidated composite. Many 
kinds of sacriﬁcial materials have been used as pore formers, such as natural and synthetic 
organics, salts, liquids, metals, and ceramic compounds. As pore formers, synthetic and natural 
organics are often extracted through pyrolysis by applying long thermal treatments at 
temperatures between 200℃ and 600℃6768. Liquids and oils can be evaporated or sublimated 
easily without the generation of unexpected toxic gases and residual stresses during the removal 
process 69 70 . Sacriﬁcial materials such as salts, ceramic and metallic particles, are usually 
extracted by chemical rather than thermal approaches. Repeatedly washing the composite with 
water can simply achieve the extraction salts71. Ceramic and metallic particles or ﬁbers need 
more aggressive agents and are usually extracted by acidic leaching7273. 
Compared with the other fabrication approaches, the main advantages of the sacriﬁcial 
template method is that the porosity, pore size distribution, and pore morphology of the ﬁnal 
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ceramic component can be decided by a suitable choice of the sacriﬁcial material. With this 
method, ceramics with porosities and average pore sizes ranging from 20% to 90% and 1–700 μ 
m can be achieved. 
2.4.3 Direct forming 
In direct foaming methods, ceramics suspension which are foamed by incorporating air or gas, 
stabilized, dried, and subsequently sintered at high temperatures to obtain consolidated 
structures. In this method, highly porous ceramic materials (up to more than 95% porosity) can 
be easily produced with low cost. On one hand the porosity of ceramics is proportional to the 
amount of gas incorporated into the suspension during the foaming process. On the other hand 
the pore size is determined by the stability of the wet foam before setting takes place. Wet foams 
are thermodynamically unstable systems because of their high gas–liquid interfacial area. Foam 
destabilization is triggered by several physical processes to decrease the system free energy. The 
three main destabilization processes are drainage (creaming), coalescence (ﬁlm rupture), and 
Ostwald ripening (disproportionation). The size of incorporated bubbles can be significantly 
increased by these destabilization processes, generating large pores in the ﬁnal cellular 
microstructure. So the approach used to stabilize the air bubbles incorporated within the initial 
suspension is the most important issue in control of the direct foaming methods. 
There are two predominant approaches stabilizing the bubble in ceramic suspension. One 
is to use surfactants which reduce the interfacial energy of the gas–liquid boundaries. But long-
chain surfactants have difficulty preventing the destabilization of foams in a short time because 
the adsorption energy of surfactants at the gas–liquid interface is relatively low. Hence, a setting 
agent is also required to stablize the foam microstructure before extensive coalescence and 
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disproportionation can occur. The ultimate pore size of the foam depends on a balance between 
the kinetics of bubble disproportionation and the speed of liquid/suspension setting. There are 
different types of surfactants such as protein, anionic, cationic and nonionic. With the surfactant-
based direct foaming method, pore sizes within the range of 35 μm to 1.2 mm can be achieved 
and porosity of cellular structures produced can be tuned from 40% to 97%. Compared with the 
replica method, the direct foaming methods usually produce dense ﬂawless struts after sintering, 
increasing the mechanical strength of the porous ceramic. 
The other approach of stabilizing the foam is using solid particles with tailored surface 
chemistry to stabilize gas bubbles. Particles adsorbed at the gas–liquid interface can prevent the 
destabilization mechanisms for several days, it is a long-term stabilization compared with the 
surfactants foaming method74. Due to its excellent stability, particle-stabilized foams can be 
directly dried and sintered to obtain the macroporous ceramic without a setting step. The porosity 
of foams produced with this method range from 40% to 93%, and the average pore sizes can be 
tuned from 10 to 300 μm. Closed-pore ceramics foams can be easily prepared with this method 
since the bubbles in the wet foam can be fully covered with a layer of surface modiﬁed particles. 
2.5 SINTERING 
Solid state sintering is the process of consolidating a mass of powder particles by the application 
of heat without melting75. The objective is to achieve the ﬁnal ceramic part by elimination of all 
the pores contained in the body. During this process, densiﬁcation of the shaped part is driven by 
reduction of the surface area of the powder and achieved by one of several mass transport 
processes. The densification mechanisms, including grain boundary diffusion and volume 
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diffusion, cause neck growth between touching particles and a reduction their center to center 
distance resulting in shrinkage and pore elimination.  In contrast, coarsening mechanisms such as 
surface diffusion cause neck formation without a reduction in center to center distance and 
thereby reduce the surface area of the powder without shrinkage and pore elimination. It is 
therefore important to use very small powder particles that increase the driving force for solid 
state sintering and use a sintering temperature at which the densification mechanisms such as 
grain boundary diffusion or volume diffusion are dominant. Sintering is extraordinary important 
because the ultimate properties of the ceramic parts strongly depend on it. Fig. 5 shows the 
microstructural changes that occur during solid state sintering. 
Pressureless sintering of HA is generally performed in the temperature ranging from 
1100℃ to 1250℃. The sintering of HA powder compact, like all ceramics, can be divided in 
three sequential stages76. (1) In the initial stage, the interparticle necks form at contacts and 
grow. This stage occurs with a little or no densiﬁcation, and it lasts till the relative density 
reaches 65% of the fully dense material. (2) In the intermediate stage, the necks have impinged 
and densiﬁcation generally occurs by the shrinking of the pore channels at triple points. The 
pores remain open and form a continuous phase in intermediate stage sintering. This stage is the 
major part of sintering, and it ends when the pores pinch off to become isolated at grain corners. 
(3) In the ﬁnal stage of sintering, the isolated pores may disappear, leaving a fully or nearly fully 
dense ceramic. During sintering of HA, densiﬁcation occurs without formation of any liquid 
phase, and structural investigations reveal no evidence of secondary phases, crystalline or 
amorphous formed77. 
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Figure 2.11 Grain growth during the sintering process78 
2.6 INFILTRATION OF POROUS CERAMICS 
Infiltration is the process of introducing a second phase into porous preforms with a liquid 
precursor that is converted into an inorganic phase during pyrolysis. The porous preforms should 
have an open-pore structure with high porosity to allow the liquid to pass into the interior. There 
are some advantages of using liquid infiltration processes. The preforms can be shaped with 
conventional methods. Then a variety of unique microstructures with particular mechanical 
properties, surface modification, and compositional gradients of the second phase can be 
achieved by controlling the infiltration processes79. In addition, the precursor can be used to 
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increase the relative density and strengthen a powder compact without shrinkage 80 . The 
advantages of the liquid infiltration technique have been used to fabricate various particulate-
reinforced ceramic composites81. 
There are some infiltration studies showed in the following: Marple and Green fabricated 
alumina/mullite ceramic and indicated that the phase distribution and the microstructure 
development can be controlled by infiltration process81. After partial sintered at 1300°C, the 
alumina cylinder compacts were immersed in prehydrolysed ethyl silicate solution for several 
different periods of time, dried and heated at 1200°C to allow the decomposition of the ethyl 
silicate. Finally, the alumina cylinder compacts were heated at 1650°C to get densified and 
mullite was formed. Similarly, in Yung-Jen Lin’s work, mullite was cyclically infiltrated into 
porous Zirconia82. In the process, the distribution of mullite was nonuniform, with higher mullite 
concentration near the external surface. After the infiltration and sintering, the gradient in second 
phase created residual stresses and cracking on cooling. This residual stress is thought to arise 
because of differential thermal expansion83. These studies support the idea that infiltration is an 
effective way to change the composition and microstructure of ceramic bodies84. 
Some research has showed the influence of Ca content on the degradability of HA85. 
Therefore Ca2+ infiltration of HA foams provides a feasible method to optimize the properties of 
calcium phosphate ceramics. In the preliminary work for this proposal, calcium nitrate solution 
was infiltrated into porous HA foam. Then the foam was immersed in ammonium hydroxide to 
form CaO particles in the HA foam before final sintering. 
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3.0  HYPOTHESIS 
Calcium phosphate has become an important biomaterial for bone tissue growth. Different 
calcium phosphate phases with various ratio of Ca/P have different bioactivity and 
biocompatibility. Hydroxyapatite with Ca/P=1.67 is reported to enhance bone marrow cell 
culturing but the disadvantage is the low degradability compared with other phase of calcium 
phosphate. Recent studies have shown that a higher calcium content in hydroxyapatite scaffolds 
might improve the degradability of the scaffold.81 And according to Hoppe Alexander’s review, 
scaffolds with higher Ca concentration also enhance osteogenesis (growth of new bone) and 
angiogenesis (growth of new blood vessels)86. 
Therefore the hypothesis of this work is that by the infiltration with Ca into porous HA 
foams, the solubility of the HA foams during the bone cell culturing can be enhanced. 
 29 
4.0  OBJECTIVES 
1. Partially sintered HA foams will be infiltrated with calcium nitrate precursors to produce 
CaO or CaCO3 phase in the new ceramic foams.  
2. The influence of Ca rich phase on structure during the dissolution will be investigated by 
SEM and micro-CT. 
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5.0  APPROACH 
5.1 4.1 MATERIAL PREPARATION 
5.1.1 Hydroxyapatite powder preparation 
First hydroxyapatite powder (SIGMA-ALDRIVH Co) was calcined at 900°C for 1 hour to insure 
the purity. Then the powder was milled in water for 24 hours. Then the powder was dried and 
granulated by pestle and mortar. 
5.1.2 High calcium phosphate ratio foam 
A HA ceramic foam was fabricated by emulsion method and then infiltrated with Ca2+ solution 
in the following process to get a high calcium content. 
First, ammonium polymethacrylate polyelectrolyte dispersant (Darvan C, RT Vanderbilt 
Co.) was added to deionized water and HCl was added to the solution adjusting the pH to 5.5. 
Second, the prepared HA powder was added to the suspension and it was stirred at 2500 RPM 
for 20 minutes to get appropriate dispersion and then the cationic surfactant (benzethonium 
chloride, Sigma) was added to the emulsion and stirred at 2500 RPM for 2 minutes. Last, 10% 
volume of heptane was added to the emulsion and stirred at high speed for 40 seconds. The 
recipe for making the foams is listed in Table 5.1 The recipe for making HA foam. 
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Table 5.1 The recipe for making HA foam 
Volume% of HA 30% 
Mass of HA 10g 
Darvan C 2.9ml 
Deionized water 4.48ml 
heptane 1.172ml 
Benzothonium Chloride 0.1776g 
A paper mold was used to contain the emulsion and it was put in a fume hood for 2 hours 
with 60% humidity and the further dried for 24 hours with 40% humidity in order to allow the 
foam expand and generate connected pores. Then the mold containing the foam was heat treated 
in a furnace for 7.18 hours in 900°C using 2°C/minute heating rate and 10°C/minutes cooling 
rate. After that the foams were partially sintered in air at 1100°C for 1 hour to get an appropriate 
amount of strength and open porosity for infiltration. 
The infiltrant was made with calcium nitrate tetrahydrate (Ca(NO3)2·4H2O, Alfa Aesar, 
England) and water. The solution concentrations were prepared with Ca2+ concentrations of 
2mol/L and 5mol/L. The foams were then evacuated to remove the air from the open pores and 
then immersed in the infiltrant. After 24 hours the foams were removed from the calcium nitrate 
solution and immersed in ammonia hydroxide solution at pH=12.5 for 30 minutes to allow the 
Ca2+ to precipitate Ca(OH)2 in the open pores of the foam. After that the foams were dried in air 
for 24 hours at room temperature and then was fired at 900°C to achieve insitu crystallization of 
CaO in the pores, and then sintered at 1300° C for 2.25 hour so the struts of the foam were fully 
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dense. The heat rate for sintering was 5°C/minute while cooling rate was 10°C/minutes. The 
open pore volume fraction in the foam was approximately 0.9. 
Finally the foams were cut into small pieces, the weight of each sample is controlled in 
the range between 0.0390g and 0.0410g. 
5.2 CHARACTERIZATION 
In order to compare foams at before and after the solubility tests, micro-CT and SEM were the 
main methods used. 
5.2.1 Micro-CT 
In order to create cross-sections of a sample that can be used to recreate 3D renderings without 
destroying the original object, X-ray microtomography was used to scan all the samples before 
and after solubility test in the scanner called SKYSCAN 1272(Micro Photonics Inc.). Low 
resolution (1224x820) and copper filter were applied during the process. After scanning, a 3D 
image reconstruction program was used to achieve 2D individual slices through the samples. 
Then a program called CTAn (Micro-CT analysis) was used to measure particular parameters of 
each samples, such as volume, close pore number, porosity and pore size distribution. 
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5.2.2 SEM test 
Scanning electron microscopy analysis was performed on the surface of the infiltrated sample 
foams including those subjected to solubility test (which will be discussed below) and untreated 
ones. The foams were coated with palladium using a sputter coater and examined in a Phillips 
XL30 scanning electron microscope, the magnification rage is from 50 to 20000. 
5.3 STATIC SOLUBILITY TEST 
Three groups of infiltrated foams with 0mol/L, 2mol/L, 5mol/L Ca2+ infiltration were prepared 
as described in Table 5.1. The samples were soaked in saline at room temperature. There were 7 
time points (30minutes, 1 hour, 1 day, 3 days, 1 week, 2 weeks and 4 weeks) and 3 samples for 
each different infiltration concentration and each time point. The number of total samples was 
63. All the samples were placed in separate sealed tubes which contained 2ml Tris-buffer Saline. 
Afterward the samples were removed from the saline after the appropriate immersion time. Then 
the foams were allowed to dry and they were coated with palladium and observed in SEM. 
Table 5.2 Time points for each group under infiltration process with different Ca2+ concentration 
 0.5hr 1 hr 1day 3days 1 week 2 weeks 4weeks 
0mol/L        
2mol/L        
5mol/L        
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6.0  RESULTS AND DISCUSSION 
6.1 WEIGHT CHANGE 
The weight of each foam was measured before and after the solubility test. And the weight 
change percentage was calculated. According to the data, a line chart with error bar was drew 
(Figure 6.1). As shown in the plot, the line representing the samples infiltrated with 5mol/L Ca+ 
solution  indicates the weight of the samples tends to decrease with time while the HA line 
shows that the weight change of pure HA foams tends to increase with the time from 30 minutes 
to 1 week then decrease with time. And the line representing 2M samples indicates that the 
weight change has the similar trend as pure HA but not notable. It is apparent that the trends are 
comparable to the size of the error bars. This is probably because the samples are small and the 
overall change in weight is less than 2% suggesting very small changes in weight and the 
interpretation is affected by the variation between the repeats and the same time point. 
Afterwards, analysis of variance (ANOVA) was used to analyze the data of weight change. 
According to the ANOVA result, at the time point of 3 days, 2 weeks and 4 weeks, the weight 
change percentage of HA samples is significantly higher than that of 5M samples meanwhile the 
weight change percentage of 2M samples is significantly higher than that of 5M samples at the 
time point of 2 weeks. It is clear that 5mol/L infiltration creates different behavior with a weight 
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loss whereas the HA and 2mol/L infiltrated samples tend to show a weight gain within the first 
400 hours. 
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Figure 6.1 Weight change percentage 
From previous unpublished results on release of calcium into the saline from HA and 2M 
samples, the HA samples didn’t release much calcium into the saline the whole time and the 
release of calcium from 2M samples increases with time87 (Figure 6.2). Therefore, we were 
expecting a weight loss in the infiltrated foams. But from the weight change result, this only 
seems to have been significant for the 5M samples. The reason for this trend becomes clearer 
when the surface of the foams were inspected by SEM and micro-CT. 
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Figure 6.2 Ca+ content in the saline after solubility test87 
6.2 SEM OBSERVATION 
After infiltration and sintering, the introduced calcium might exist in the form of CaO or 
Ca(OH)2. CaCO3 also has a possibility of existing because of the reaction between Ca(OH)2 and 
CO2 in the air. All these phases will be termed as Ca rich phase relative to HA in the following 
discussion. 
Figure 6.3 showed that all three sample conditions (HA, 2M and 5M) initially have 
smooth surface with a relatively low density of pores. As shown in the images, it is obvious that 
the density of pore of 5M samples is higher than that of 2M samples and pure HA. It indicates 
that the infiltration process might slightly increase the porosity of foams. 
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Figure 6.3 SEM images of surface of foams before solubility test (a) HA foam, (b) 2M foam, (c) 
5M foam 
After 1 hour of immersion (Figure 6.4), there is no distinct change in pure HA samples 
and no damage can be observed. For 2M samples, some damage can be observed. For 5M 
samples, there is some more defects and damage on the surface. 
 38 
 
Figure 6.4 SEM images of surface of foams after 1 hour of immersion in TBS (a) HA foams, (b) 
2M foams, (c) 5M foams 
After 1 day of immersion (Figure 6.5), there is still no distinct change in pure HA foams. 
But for 2M samples, there is a large amount of needle-shaped phase (thought to be amorphous 
calcium phosphate precipitates85) on the surface and a relatively higher density of pitting on 
other place. For 5M samples, there are also many small defects on the edge of the frame. There is 
clearly more damage on the infiltrated samples. 
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Figure 6.5 SEM images of surface of foams after 1 day of immersion in TBS (a) HA foams, (b) 
(c) 2M foams, (d) 5M foams 
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After 3 days of immersion (Figure 6.6), pure HA samples still have a smooth surface 
while some precipitation of the needle-shaped phase has occurred widely over the surface of 2M 
samples. For 5M samples, only a little amorphous precipitation can be found on the surface and 
the depth of pitting is greater than that in Figure 6.6 (d). 
 
Figure 6.6 SEM images of surface of foams after 3 days of immersion in TBS (a) (b) HA foams, 
(c) (d) 2M foams, (e) (f) 5M foams 
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After 1 week (Figure 6.7), there is no change in pure HA and 2M samples relative to the 
3 day time point. But the defects and pitting in 5M samples appear to even deeper. 
 
Figure 6.7 SEM images of surface of foams after 1 week of immersion in TBS (a) HA foams, (b) 
(c) 2M foams, (d) (e) 5M foams 
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After 4 weeks (Figure 6.8), some crystal precipitates was found on certain locations of 
the surface, this may be responsible for the small weight gain in the HA during the immersion in 
saline. The 2M foams show pits but also extensive precipitation. In contrast deeper pitting and 
more damage can be observed on the 5M samples. 
 
Figure 6.8 SEM images of surface of foams after 4 weeks of immersion in TBS (a) (b) HA foams, 
(c) (d) 2M foams, (e) (f) 5M foams 
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Summary: (i) The SEM observation appear to be in accordance with the weight change 
results. The reason for the weight gain of pure HA foams may because of the crystals generated 
from drying the saline during the test. (ii) 2M samples show surface precipitation and it increases 
with time. (iii) 5M samples show deeper pitting and more damage with time and few 
precipitates. 
And from previous unpublished XRD result of the 2M samples (Figure 6.9), the presence 
of minor amounts of crystalline phases CaCO3 that have been readily detected
8787. 
 
Figure 6.9 X-ray diffraction patterns of powder of 2M samples87  
6.3 MICRO-CT 
From the Micro-CT images, some properties, such as porosity, surface area, volume of foams, 
numbers of close pores and pore size distribution, can be calculated by the analysis program. But 
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due to the very large size of the pores relative to the size of the sample and the very high pore 
volume fraction it was not possible to close many of the pore sections from the slices for analysis 
of the pore size distribution and so this was not presented. Only the closed pores in the struts of 
the foam were analyzed. 
Figure 6.10 shows the porosity of samples before and after the solubility test (4 weeks, 2 
weeks, 1 week and 3days). From the figure, there is no significant trend can be observed and all 
the samples have porosities between 85% and 95%. 
 
Figure 6.10 Porosity of samples before and after solubility test 
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Figure 6.11 and Figure 6.12 show the surface and porosity change percentage, 
respectively. The surface change tendency of HA and 5M samples are both similar to the 
porosity change. These changes don't show clear trends because of the variability of samples. 
Fig. Figure 6.12 suggests some increase in porosity for many samples that could be associated 
with some fragmentation. And it is apparent that the changes occurring on immersion such as the 
surface precipitation and the pitting occur at a too high magnification to affect the micro-CT 
results. 
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Figure 6.11 Surface change percentage of pure HA, 2M and 5M samples 
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Figure 6.12 Porosity change percent of pure HA, 2M and 5M samples 
During the immersion, the numbers of closed pores in 2M and 5M samples were 
expected to decrease with time due to the fragmentation. But as showed in Figure 6.13, the 
numbers of closed pores changed irregularly. 
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Figure 6.13 Number of closed pores in samples before and after the solubility test 
Figure 6.14 shows the images of samples before and after the 4 weeks solubility test on 
approximate the same slice. These images show the microstructure clearly, we can observe the 
large pores that create large pore sections intersecting with the frame and cannot be closed and 
the small pores in the solid struts that are usually closed sections. But the problem of the 
comparison is when the sample was placed on the mount, the central axis of the sample was not 
perpendicular with the horizontal plane and the angle between the axis and the horizontal plane 
before and after the solubility test may not be the same. So the comparison of the cross sections 
can just be qualitative. 
From Figure 6.14, there isn’t much difference for all samples before and after the 
solubility test. It indicates that the minor difference observed in SEM images can’t be showed in 
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micro-CT comparisons. And most important of all, there is no clear evidence of fragmentation 
can be observed. 
 
Figure 6.14 Cross section images of samples before and after the 4 weeks solubility test (a) (b)2M 
sample, (c) (d) 5M samples 
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7.0  CONCLUSION 
1. A highly porous, approximately 90% pore space, calcium rich HA was fabricated by 
infiltrating calcium salt solution into HA foam that had been fabricated by an emulsion 
direct foaming method. The infiltration and sintering process produce HA with minor phases 
including CaCO3. 
2. The HA foam infiltrated with 5mol/L Ca+ was the only sample that showed a weight loss 
and significant damage during the immersion in saline. 
3. The 2M samples showed a lot of surface precipitation with some damage and no significant 
weight loss. 
4. There is no evidence of large scale fragmentation of the foams during immersion for any of 
the samples studied. 
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8.0  FUTURE WORK 
1. To reduce the effect of the variety of foam samples, larger and more samples should be used 
to repeat the solubility tests for each condition in the solubility test. 
2. Comparison of micro-CT experiments should be conducted on the same sample in 
interrupted immersion experiments. This would avoid the problems with sample variability. 
3. Foams should be tested with higher fractions of the calcium rich phases or tetracalcium 
phosphate by further increasing the calcium to phosphorous ratio in the powder used to 
make the foams. 
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